...Cetuximab; Tyrosine kinase inhibitors; Targeted therapy [gap=627]关键词: 胆管癌; 表皮生长因子受体信号通路; k-ras; 西妥昔; 酪氨酸酶抑制剂; 靶向治疗 ...
基于46个网页-相关网页
西妥昔单抗 Cetuximab ; Erbitux
西妥昔单抗注射液 Cetuximab Solution for Infusion ; Erbitux ; Cetuximab Solution ; Cetuxim
如西妥昔单抗 Cetuximab Erbitux
西妥昔单抗的化学合成 Cetuximab
法国及美国应用西妥昔单抗治疗直肠结肠癌最多，而芬兰最低。
The use of cetuximab for colorectal cancer was highest in France and the United States and lowest in Finland.
两项对联合应用贝伐单抗和西妥昔单抗的随机试验结果还须等待。
The results of two randomized trials looking at the combination of bevacizumab and cetuximab are awaited.
欧洲药品局emea已经限制西妥昔单抗和帕尼单抗在这些患者使用。
EMEA, the European Medicines Agency, has already restricted use of cetuximab and panitumumab to such patients.
应用推荐